Suppr超能文献

[参麦注射液治疗慢性心力衰竭的疗效与安全性系统评价]

[Systematic review of efficacy and safety of shenmai injection for chronic heart failure].

作者信息

Chen Hong-Dong, Xie Yan-Ming, Wang Lian-Xin, Wu Jiu-Bin

出版信息

Zhongguo Zhong Yao Za Zhi. 2014 Sep;39(18):3650-61.

Abstract

The paper is to evaluate the efficacy and safety of Shenmai injection for chronic heart failure, retrieving the Pubmed, CBM, CNKI, Wanfang database and VIP database to comprehensively collect all types research report of Shenmai injection for chronic heart failure (CHF). Particularly wishing to point out, randomized controlled trials are include for the evaluation of effectiveness, which are statistically analyzed and evaluated by Rev-Man 5. 2. The current studies show that the improvement rate of NYHA classification of cardiac function of CHF patients and their related indexes figure such as LVEF, SV, CO, BNP, 6 min walking test value are all improved by the combination of Shenmai injection and foundation treatment. However, HR is almost no improvement. Meanwhile, serious ADR/AE of Shenmai injection for CHF isn't appear.

摘要

本文旨在评价参麦注射液治疗慢性心力衰竭的有效性和安全性,检索Pubmed、CBM、CNKI、万方数据库及维普数据库,全面收集参麦注射液治疗慢性心力衰竭(CHF)的各类研究报道。特别指出的是,纳入随机对照试验进行有效性评价,并采用Rev-Man 5.2软件进行统计分析和评价。目前研究表明,参麦注射液联合基础治疗可提高CHF患者心功能NYHA分级的改善率及其相关指标,如左室射血分数(LVEF)、每搏输出量(SV)、心输出量(CO)、脑钠肽(BNP)、6分钟步行试验值等均有所改善。然而,心率几乎无改善。同时,参麦注射液治疗CHF未出现严重不良反应/不良事件。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验